Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance and Sygen Pen Animal-Genotyping Collaboration

NEW YORK, Dec. 2 (GenomeWeb News) - Genaissance Pharmaceuticals and Sygen International will perform genotyping studies on three undisclosed meat animal species, the firms said today.

 

Genaissance will apply its HAP technology platform to conduct the study.

 

UK-based Sygen is an animal breeding concern, which has two subsidiaries. One provides breeding stock to the North American pork industry, and the other supplies shrimp for cultivation.

 

Terms of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.